Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells

The diverse roles of interferon‐α (IFN‐α) in regulating the immune response to infectious agents suggested that it might affect dendritic cell (DC) development. Peripheral blood mononuclear cells cultured with IFN‐α and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) developed a dendritic morphology and expressed high levels of the class I and II human leukocyte antigens (HLA), B7 costimulatory molecules, adhesion proteins, and CD40. Elevated DC expression of B7‐2 and HLA‐DR was observed with increasing IFN‐α concentrations up to 5000 U/mL. The effects of IFN‐α on DC immunophenotype were not reversed by adding neutralizing antibodies against interleukin‐4 (IL‐4) or tumor necrosis factor α to the cell cultures or by eliminating lymphocytes from the cultures. The addition of IFN‐α to cultures containing optimal concentrations of IL‐4 and GM‐CSF significantly increased the B7‐2 and HLA‐DR levels above those present on DCs grown in two cytokines. The DCs generated with IFN‐α and GM‐CSF were potent antigen‐presenting cells in allogeneic mixed leukocyte reactions. They also were capable of taking up, processing, and presenting tetanus toxin to autologous T lymphocytes. These results demonstrate an important role for IFN‐α in the generation of DCs with potent antigen‐presenting capabilities from peripheral blood monocytes. J. Leukoc. Biol. 64: 358–367; 1998.

[1]  H. Klocker,et al.  In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy. , 1997, Experimental hematology.

[2]  J. Banchereau,et al.  CD40 Ligation on Human Cord Blood CD34+Hematopoietic Progenitors Induces Their Proliferation and Differentiation into Functional Dendritic Cells , 1997, The Journal of experimental medicine.

[3]  G. Delespesse,et al.  T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells. , 1997, Journal of immunology.

[4]  O. Majdic,et al.  TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. , 1996, Journal of immunology.

[5]  G. Schuler,et al.  High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.

[6]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[7]  J. Sprent,et al.  Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.

[8]  S. Nakagawa,et al.  Interferon‐γ and interleukin‐10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7‐1) expression , 1996, European journal of immunology.

[9]  A. Enk,et al.  Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cells , 1996, European journal of immunology.

[10]  Liangji Zhou,et al.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Banchereau,et al.  Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. , 1996, Blood.

[12]  G. Trinchieri,et al.  IL-12 synthesis by human Langerhans cells. , 1996, Journal of immunology.

[13]  Michael D. Roth,et al.  Human CD14+ leukocytes acquire the phenotype and function of antigen‐presenting dendritic cells when cultured in GM‐CSF and IL‐4 , 1996, Journal of leukocyte biology.

[14]  A. Anichini,et al.  Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. , 1995, Experimental hematology.

[15]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[16]  M. Cavazzana‐Calvo,et al.  Characteristics of antigen‐independent and antigen‐dependent interaction of dendritic cells with CD4+ T cells , 1995, Advances in experimental medicine and biology.

[17]  G. Trinchieri,et al.  Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. , 1995, Journal of immunology.

[18]  J. Banchereau,et al.  B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells , 1994, The Journal of experimental medicine.

[19]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[20]  P. Linsley,et al.  Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. , 1994, Journal of immunology.

[21]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[22]  E. Petricoin,et al.  IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma-induced cellular gene expression in monocytes and monocytic cell lines. , 1993, Journal of immunology.

[23]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[24]  J. Peters,et al.  Human Blood Dendritic Cells Exhibit a Distinct T‐Cell‐Stimulating Mechanism and Differentiation Pattern , 1992, Scandinavian journal of immunology.

[25]  P. Linsley,et al.  Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations , 1992, The Journal of experimental medicine.

[26]  C. Harding,et al.  Processing and presentation of intact hen egg‐white lysozyme by dendritic cells , 1992, European journal of immunology.

[27]  B. Chain,et al.  Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Steinman,et al.  The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. , 1992, The Journal of clinical investigation.

[29]  J. McKenzie,et al.  Adhesion molecules on human tonsil dendritic cells. , 1992, Transplantation.

[30]  C. Snapper,et al.  Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice , 1991, The Journal of experimental medicine.

[31]  C. Meijer,et al.  Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes , 1991, European journal of immunology.

[32]  S. Aiba,et al.  The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent. , 1991, Journal of immunology.

[33]  J. Hopkins,et al.  Uptake of antigen by afferent lymph dendritic cells mediated by antibody , 1990, European journal of immunology.

[34]  R. Steinman,et al.  The distinct surface of human blood dendritic cells, as observed after an improved isolation method. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Misawa,et al.  Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture. , 1990, Blood.

[36]  M. Lohoff,et al.  Murine IL-4 antagonizes the protective effects of IFN on virus-mediated lysis of murine L929 fibroblast cells. , 1990, Journal of immunology.

[37]  O. Majdic,et al.  Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. , 1989, The Journal of investigative dermatology.

[38]  R. Willemze,et al.  Inhibition of human macrophage colony formation by interleukin 4 , 1989, The Journal of experimental medicine.

[39]  P. King,et al.  Human tonsillar dendritic cell‐induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies , 1989, European journal of immunology.

[40]  R. Steinman,et al.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.

[41]  D. Williams,et al.  Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. , 1988, Journal of immunology.

[42]  J. McKenzie,et al.  Isolation and characterization of human tonsil dendritic cells , 1988, The Journal of experimental medicine.

[43]  D. Rennick,et al.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Paul,et al.  Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. , 1987, Blood.

[45]  M. Berkowitz,et al.  Differentiation of dendritic cells in cultures of rat bone marrow cells , 1986, The Journal of experimental medicine.

[46]  N. Young,et al.  Studies of interferon as a regulator of hematopoietic cell proliferation. , 1985, Journal of immunology.

[47]  J. Kirkwood,et al.  Analysis of granulocyte-macrophage progenitor cells in patients treated with recombinant interferon alpha-2. , 1985, The American journal of medicine.

[48]  G. Stark,et al.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells , 1984, Cell.

[49]  L. Juliano,et al.  Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. , 1983, Journal of immunology.

[50]  D. Sachs,et al.  Epidermal Langerhans cells are derived from cells originating in bone marrow , 1979, Nature.

[51]  I. Gresser,et al.  Enhanced NK cell activity in mice injected with interferon and interferon inducers , 1978, Nature.

[52]  B. Löwenberg,et al.  Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. , 1978, Cancer research.

[53]  P. Greenberg,et al.  Cytotoxic effects of interferon in vitro on granulocytic progenitor cells. , 1977, Cancer research.

[54]  W. A. Fleming,et al.  The effects of an inhibiting factor (interferon) on the in vitro growth of granulocyte-macrophage colonies. , 1972, Immunology.

[55]  W. A. Fleming,et al.  The relationship between serum interferon and an inhibitor of mouse haemopoietic colonies in vitro. , 1971, Immunology.

[56]  J. Banchereau,et al.  Recent advances in the study of dendritic cells and follicular dendritic cells. , 1995, Immunology today.

[57]  S. Carsons,et al.  Stem cell factor augments tumor necrosis factor‐granulocyte‐macrophage colony‐stimulating factor‐mediated dendritic cell hematopoiesis , 1995, Stem cells.

[58]  R. Ransohoff,et al.  Interferon-induced antiviral actions and their regulation. , 1993, Advances in virus research.

[59]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[60]  E. Demaeyer,et al.  Interferons and other regulatory cytokines , 1988 .

[61]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[62]  A. Ganser,et al.  Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. , 1987, Blood.